​

LeonaBio (LONA) Stock Forecast, Price Target & Predictions

OverviewFinancialsChart

LONA Stock Forecast

LeonaBio (LONA) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $10.00, with a high of $10.00 and a low of $10.00. This represents a 77.94% increase from the last price of $5.62.

$2 $3 $4 $5 $6 $7 $8 $9 $10 High: $10 Avg: $10 Low: $10 Last Closed Price: $5.62

LONA Stock Rating

LeonaBio stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (57.14%), 3 Hold (42.86%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 3 4 Strong Sell Sell Hold Buy Strong Buy

LONA Price Target Upside V Benchmarks

TypeNameUpside
StockLeonaBio77.94%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts112
Avg Price Target$10.00$10.00$7.00
Last Closing Price$5.62$5.62$5.62
Upside/Downside77.94%77.94%24.56%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 26--2--2
Jan, 26--2--2
Dec, 25--2--2
Nov, 25--2--2
Oct, 25--2--2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 18, 2026Mizuho Securities$10.00$4.76110.08%77.94%
Sep 19, 2025Graig SuvannavejhMizuho Securities$4.00$3.834.44%-28.83%
Jun 22, 2022Andrew TsaiJefferies$3.00$2.855.26%-46.62%
Apr 21, 2022Berenberg Bank$33.00$11.63183.75%487.19%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 26, 2026Cantor FitzgeraldOverweightinitialise
Sep 04, 2024Rodman & RenshawBuyNeutraldowngrade
Sep 04, 2024JMP SecuritiesPerformMarket Performdowngrade
Sep 04, 2024JMP SecuritiesMarket OutperformPerformdowngrade
Sep 04, 2024BTIGNeutralPositivedowngrade
Sep 03, 2024BTIGNeutraldowngrade
Aug 19, 2024Rodman & RenshawBuyinitialise
Oct 17, 2022JMP SecuritiesMarket Outperformupgrade
Jun 22, 2022JefferiesBuydowngrade

Financial Forecast

EPS Forecast

$-30 $-24 $-18 $-12 $-6 $0 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-25.20-----
Avg Forecast$-25.10$-6.24$-4.87$-0.40$-0.43$-0.45
High Forecast$-25.10$-6.24$-4.71$-0.40$-0.43$-0.45
Low Forecast$-25.10$-6.24$-5.03$-0.40$-0.43$-0.45
Surprise %0.40%-----

Revenue Forecast

Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported------
Avg Forecast------
High Forecast------
Low Forecast------
Surprise %------

Net Income Forecast

$-100M $-80M $-60M $-40M $-20M $0 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-96.94M-----
Avg Forecast$-96.59M$-24.02M$-18.74M$-1.54M$-1.65M$-1.73M
High Forecast$-96.59M$-24.02M$-18.13M$-1.54M$-1.65M$-1.73M
Low Forecast$-96.59M$-24.02M$-19.35M$-1.54M$-1.65M$-1.73M
Surprise %0.37%-----

LONA Forecast FAQ

Is LeonaBio stock a buy?

LeonaBio stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that LeonaBio is a favorable investment for most analysts.

What is LeonaBio's price target?

LeonaBio's price target, set by 7 Wall Street analysts, averages $10 over the next 12 months. The price target range spans from $10 at the low end to $10 at the high end, suggesting a potential 77.94% change from the previous closing price of $5.62.

How does LeonaBio stock forecast compare to its benchmarks?

LeonaBio's stock forecast shows a 77.94% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for LeonaBio over the past three months?

  • February 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is LeonaBio’s EPS forecast?

LeonaBio's average annual EPS forecast for its fiscal year ending in December 2025 is $-6.24, marking a -75.24% decrease from the reported $-25.2 in 2024. Estimates for the following years are $-4.87 in 2026, $-0.4 in 2027, $-0.43 in 2028, and $-0.45 in 2029.

What is LeonaBio’s revenue forecast?

LeonaBio's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $0, followed by $0 for 2027, $0 for 2028, and $0 for 2029.

What is LeonaBio’s net income forecast?

LeonaBio's net income forecast for the fiscal year ending in December 2025 stands at $-24.015M, representing a -75.23% decrease from the reported $-96.94M in 2024. Projections indicate $-18.74M in 2026, $-1.539M in 2027, $-1.655M in 2028, and $-1.732M in 2029.